These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26261591)

  • 1. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers.
    Melling N; Grimm N; Simon R; Stahl P; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
    Pathol Oncol Res; 2016 Jan; 22(1):95-102. PubMed ID: 26347467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
    Beca F; Andre R; Martins DS; Bilhim T; Martins D; Schmitt F
    J Clin Pathol; 2014 Nov; 67(11):961-7. PubMed ID: 25053543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
    Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
    Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
    Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer.
    Melling N; Muth J; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
    Diagn Pathol; 2015 Jul; 10():125. PubMed ID: 26208856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
    Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
    J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Ki67 expression is an independent good prognostic marker in colorectal cancer.
    Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
    J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.
    Cai Z; Ke J; He X; Yuan R; Chen Y; Wu X; Wang L; Wang J; Lan P; Wu X
    Ann Surg Oncol; 2014 Jan; 21(1):179-88. PubMed ID: 23907312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
    Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
    Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
    Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
    Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High SHIP2 expression indicates poor survival in colorectal cancer.
    Yang J; Fu M; Ding Y; Weng Y; Fan W; Pu X; Ge Z; Zhan F; Ni H; Zhang W; Jin F; Xu N; Li J; Qiu L; Wang J; Gu X
    Dis Markers; 2014; 2014():218968. PubMed ID: 25525286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic correlation between MTA2 expression level and colorectal cancer.
    Ding W; Hu W; Yang H; Ying T; Tian Y
    Int J Clin Exp Pathol; 2015; 8(6):7173-80. PubMed ID: 26261611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
    Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
    J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
    Benedix F; Kuester D; Meyer F; Lippert H
    Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.
    Al-Maghrabi J; Emam E; Gomaa W; Al-Qaydy D; Al-Maghrabi B; Buhmeida A; Abuzenadah A; Al-Qahtani M; Al-Ahwal M
    Int J Clin Exp Pathol; 2015; 8(12):15895-902. PubMed ID: 26884861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.